
About Breakthrough2023
ArisGlobal’s annual Breakthrough a one of a kind event that brings together key leaders of the life sciences and digital health community to provide unique insights around the innovation, processes, talent and technology that drives greater efficiency, strategy, results for businesses. Technology in automation, data and analytics, ML and AI will be featured to drive the end to end workflow. This year’s event will feature sessions and keynotes by leading voices from across the industry, aimed at sharing ideas, experiences, and best practices. We are featuring a Technology Innovation Center that will host live demonstrations across the LifeSphere platform to showcase cutting edge capabilities, use cases, plus enable networking with ArisGlobal preferred partners as part of our open ecosystem. Event admission early bird special $100 per person.
May
24th-25th, 2023
Chicago
Illinois, United States
Top
Industry Speakers
$100 Admission
Early Bird Until 3/31

Who Should Attend
Breakthrough2023 is about understanding how technology is transforming the future for humanity. Sessions will be geared towards a variety of audiences, such as life sciences and digital health professionals, automation and innovation advocates, and health technology journalists.
Breakthrough by the Numbers
Top Biopharmas
Represented
Life Science Leaders
Attending
Inspiring
Speakers
Hear from past
attendees
Johnson & Johnson
“This is a great opportunity to connect and build a bigger partnership with life sciences peers and regulators”
Boehringer Ingelheim
“A tremendous event to learn from industry thought leaders and move life sciences forward”
Here’s What to Expect At This Year’s
Breakthrough Conference
![]() |
May 24th - Day 1 |
|
|
![]() |
May 25th - Day 2 |
|

Mike Gordon
Chief Executive Officer, ArisGlobal Chairman of the Board
With more than 18 years of experience, Mike Gordon has held several senior-level global leadership roles of increasing scope and responsibility, mainly within technology-focused organizations. Mr. Gordon’s most recent corporate leadership role was with Callcredit Information Group as Chief Executive Officer, where he oversaw a successful transformation of the business and an eventual sale to Transunion. Mr. Gordon also currently serves on the board of directors of three technology companies, Fintech, Hometrack and Constructonline.
Prior to Callcredit Information, Mr. Gordon served as FICO’s Executive Vice President of Sales, Services, and Marketing, after serving in various roles of increasing responsibility across the company’s banking, insurance, retail, health care and pharmaceutical markets. Before joining FICO in 2005, Mr. Gordon spent more than 13 years in the financial services industry. As a vice president at Capgemini (formerly Ernst & Young Consulting LLP) his competency was in providing strategic and operational solutions to banking and insurance providers, leading the Insurance Center of Excellence and Solutions.
Mr. Gordon received a BS in Industrial Engineering / Operations Research from Northwestern University and an MBA in Finance and Business Economics from The University of Chicago Graduate School of Business.

Kelly Hnat
Principal, K2 Consulting
Kelly is a recognized industry leader in RIM and IDMP with over 20 years experience in the pharmaceutical industry, the last 11 focused on Regulatory Affairs. She has led both IT and RIM/Reg Ops organizations in several companies and has overseen implementation of large-scale global systems and processes. Kelly is passionate about the possibilities for pharma companies to improve productivity and compliance through process-focused management of critical data. She is an industry leader on the EMA SPOR Task Force and its PMS subteam and is also involved in ISO TC/215.

Pat Jenakanandhini
Chief Product Officer, ArisGlobal
Pat Jenakanandhini serves as ArisGlobal’s Chief Product Officer, where he oversees all product strategy and management functions. Prior to ArisGlobal, Pat served as Senior Vice President of Products at Accruent and Chief Technology Officer at BlueCielo, acquiring several years of experience building and delivering SaaS products including serving. During his tenure at Accruent, the company completed 5 acquisitions, built a strong product strategy driving growth that eventually led to Accruent being acquired by Fortive, a large publicly listed company. At BlueCielo, Pat was responsible for driving the transformation of the product, the business and the culture of product & engineering teams to focusing on SaaS. Pat is passionate about building great software that delights users, solves real business problems and provides a superior user experience. Pat lives just outside Boston, MA with his wife, 2 kids and dog. Pat loves building things, home automation, playing video games, and traveling the world. He has an MBA in Finance and dual degrees in Computer Science and Process & Piping Design.

Claudia Lehmann
Vice President, Patient Safety & Pharmacovigilance Operations & Systems, Boehringer Ingelheim
Claudia Lehmann serves as Vice President of Patient Safety & Pharmacovigilance Operations & Systems for Boehringer Ingelheim. Prior to this role, she was leading Biostatistics and Data Management Europe within Boehringer Ingelheim, Claudia is a member of the ICH MedDRA Management Committee and an SME on the Eudravigilance EWG.
Claudia has been trained in medical information management at an affiliation of the University of Ulm, Germany

Jennifer Manochio
Senior Director, Global Safety Systems, Bristol Myers Squibb
Jennifer is Senior Director of the Global Safety Systems team within the World Wide Patient safety organization at Bristol Myers Squibb. In her 18 year tenure with BMS, she has led two Global Safety Database implementations and built the dedicated team that provides stewardship of the organization’s systems, while actively driving system roadmaps.
Jennifer is passionate about the possibilities of safety organizations improving their business value, quality, and ultimately empowering more effective and efficient patient safety through standardization of systems and process.
Prior to joining the Pharmaceutical industry, Jennifer worked as an Oncology nurse for Princeton Medical Center.

Rob Scott, MD
Chairman, ArisGlobal Advisory Board
Dr. Scott has been appointed the Chairman of the Advisory Board, in addition to serving as a member of ArisGlobal’s Board of Directors. Dr. Scott joins the board with over 30 years of experience in the life sciences industry, most recently serving as the Chief Medical Officer and Head of Development at AbbVie, where he led a team of more than 4,000 individuals across 52 countries.

Marina Suvakov
Global Head, Product Safety Surveillance, PMI Life Sciences
Marina is a passionate, experienced, and motivated professional with over 13 years of experience in the pharmaceutical industry, particularly safety surveillance. Her expertise and experience in pharmacovigilance and quality activities, combined with her innovative thinking style and enthusiasm has helped many companies and departments propel through their transformation journeys. Her expertise are in process optimization and ensuring standards and compliance within the GVP guidelines. Marina holds a master’s degree in pharmaceutical sciences from Greenwich University and a bachelor’s degree in medical biochemistry from Brunel University.

Gary Wilson
Managing Director & Co-Founder, CorrIT - SPORIFY
Gary is Managing Director & Co-Founder of CorrIT and creator of the SPORIFY web application. Gary holds a BSc (Hons) in Computer Science and has over 18 years industry and consultancy experience. Since the launch of SPORIFY in 2017, CorrIT have assisted many organisations and regulators with their implementation and integration of SPOR Master Data Services as they move towards IDMP in Europe and has a sharp focus on a data first approach with global reference data management and interoperability of systems. Gary is a member of the SPOR Key Use Group and IDMP inter-association group.

Kristy Wort
Vice President, Clinical Operations, TOTAL Diversity Clinical Trial Management
Kristy Wort serves as the Vice President of Clinical Operations for Total Diversity Clinical Trial Management (TOTAL). In this role, she has strategic oversight across clinical operations.
Before joining TOTAL in 2017, Wort started her career at a research site as a Recruitment Manager and eventually moved into a position as a Global Project Manager. She has more than 20 years of experience in operational delivery in clinical trials, including global regulations, cultures, and customs relevant to the successful implementation of projects in the clinical trial industry.
Wort has a vast array of therapeutic experience, including women’s health, dermatology, hematology/oncology, rare disease, nervous system and endocrine/metabolic just to name a few.
Kristy earned a Bachelor’s degree in marketing from the Intercontinental University in Atlanta. She holds a white belt certification in risk-based management.
Breakthrough2023 FAQs
Click on each row below to learn more.
The two-day conference will feature Keynotes, Breakout Sessions, and an Innovation Centre for ArisGlobal’s partners, customers, and industry peers to gather to collaborate, share ideas, network, and learn about ArisGlobal’s products and gain insights into innovation, AI and digital transformation.
Sessions will be geared towards a variety of audiences, such as life sciences and digital health professionals, automation and innovation advocates, and health technology journalists.
Breakthrough will be in Chicago, IL
The Conference is an in-person event, no virtual component will be available
- CEO Keynote
- Industry Trends in Health Tech
- LifeSphere® Updates: Product Launches and Roadmaps
- Data & Analytics Panel
- Winning with Automation: What's Possible Now and What’s Ahead
- The Future Vision of Safety
- Artificial Intelligence and Machine Learning Panel Discussion
- Myths and Realities on Machine Learning in Life Sciences
- CRO Challenges, Opportunities, and Tech Solutions Panel
- Emerging Drug Development Challenges and Solutions
- Post Implementation Best Practices and Transformation: Adoption and Optimization
- Data and Analytics: Real Time Reporting, Advanced Signaling, and Causal Pathways
- Next Gen Reporting Advancements
- Intelligent Content Management
- Regulatory Trends Panel
- Solutions for Cross-Department Interconnectivity
There are a mix of session programming, ranging from 20 minutes – 90 minutes.
We are not formally offering this service, however, if you have a particular session you would like to join, please contact [email protected] and we will look to arrange this
Yes please email [email protected] for sponsorship packages.
Please contact [email protected] if you have any questions regarding Breakthrough2023.
- Pricing Tier
- Early Bird
- Regular
- At the door
- Dates
- February 1 – March 31, 2023
- April 1 – May 23, 2023
- May 24 – May 25, 2023
- Registration Price
- $100
- $150
- $150
All major credit cards are accepted for registration payments via EventBrite (Visa, Mastercard, American Express, & Discover)
Submit all cancellation requests to [email protected]
Applicable refunds will be processed based on the time and date that the request was submitted:- Full refund: Cancellation notices must be received by May 1, 2023
- No refunds for requests received after May 1, 2023 Non-attendance does not constitute cancellation
To transfer your registration to someone else at your company, please email the following information for the new registrant to [email protected]
- First Name & Last Name
- Job Title
- Work Address
- Email Address
- Work Phone Number
A registration confirmation email will be sent to the new registrant once the substitution is confirmed.
ArisGlobal secured a room block at the conference venue for attendees. Confirmed registered attendees will be given access to a special discounted rate. Hotel bookings need to be made by May 3, 2023